drugset / Trial / NCT00911092
Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer
Non-randomizedSingle-groupOpen-label
Summary
The scope of the trial is to predict the early complete clinical response to exclusive concomitant radiochemotherapy in esophageal cancer by the study of the pre- and per- therapeutic proteomic profile.
Timeline
- Start
- 2007-10
- Primary completion
- 2011-09
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 1000 mg/m2 | — |